These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 36632988)

  • 1. Ethnic disparities in the immune microenvironment of triple negative breast cancer and its role in therapeutic outcomes.
    Zajac KK; Malla S; Babu RJ; Raman D; Tiwari AK
    Cancer Rep (Hoboken); 2023 Sep; 6 Suppl 1(Suppl 1):e1779. PubMed ID: 36632988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune microenvironment of triple-negative breast cancer in African-American and Caucasian women.
    O'Meara T; Safonov A; Casadevall D; Qing T; Silber A; Killelea B; Hatzis C; Pusztai L
    Breast Cancer Res Treat; 2019 May; 175(1):247-259. PubMed ID: 30725384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the tumor microenvironment to improve clinical outcomes in triple negative breast cancer patients and bridge the current disparity gap.
    Alharbi M; Roy AM; Krishnan J; Kalinski P; Yao S; Gandhi S
    Front Immunol; 2024; 15():1428118. PubMed ID: 39072334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-Stroma-Inflammation Networks Promote Pro-metastatic Chemokines and Aggressiveness Characteristics in Triple-Negative Breast Cancer.
    Liubomirski Y; Lerrer S; Meshel T; Rubinstein-Achiasaf L; Morein D; Wiemann S; Körner C; Ben-Baruch A
    Front Immunol; 2019; 10():757. PubMed ID: 31031757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative assessment of the immune microenvironment in African American Triple Negative Breast Cancer: a case-control study.
    Yaghoobi V; Moutafi M; Aung TN; Pelekanou V; Yaghoubi S; Blenman K; Ibrahim E; Vathiotis IA; Shafi S; Sharma A; O'Meara T; Fernandez AI; Pusztai L; Rimm DL
    Breast Cancer Res; 2021 Dec; 23(1):113. PubMed ID: 34906209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory T cells: Their role in triple-negative breast cancer progression and metastasis.
    Malla RR; Vasudevaraju P; Vempati RK; Rakshmitha M; Merchant N; Nagaraju GP
    Cancer; 2022 Mar; 128(6):1171-1183. PubMed ID: 34990009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Racial Disparities in Triple Negative Breast Cancer: A Review of the Role of Biologic and Non-biologic Factors.
    Prakash O; Hossain F; Danos D; Lassak A; Scribner R; Miele L
    Front Public Health; 2020; 8():576964. PubMed ID: 33415093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the interplay between triple-negative breast cancer stem cells and tumor microenvironment for effective therapeutic strategies.
    Zou Z; Luo T; Wang X; Wang B; Li Q
    J Cell Physiol; 2024 Aug; 239(8):e31278. PubMed ID: 38807378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Contribution of Race to Breast Tumor Microenvironment Composition and Disease Progression.
    Kim G; Pastoriza JM; Condeelis JS; Sparano JA; Filippou PS; Karagiannis GS; Oktay MH
    Front Oncol; 2020; 10():1022. PubMed ID: 32714862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic Potential of Thymoquinone in Triple-Negative Breast Cancer Prevention and Progression through the Modulation of the Tumor Microenvironment.
    Adinew GM; Taka E; Mochona B; Badisa RB; Mazzio EA; Elhag R; Soliman KFA
    Nutrients; 2021 Dec; 14(1):. PubMed ID: 35010954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Taraxacum mongolicum extract inhibited malignant phenotype of triple-negative breast cancer cells in tumor-associated macrophages microenvironment through suppressing IL-10 / STAT3 / PD-L1 signaling pathways.
    Deng XX; Jiao YN; Hao HF; Xue D; Bai CC; Han SY
    J Ethnopharmacol; 2021 Jun; 274():113978. PubMed ID: 33716082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racial Disparity and Triple-Negative Breast Cancer in African-American Women: A Multifaceted Affair between Obesity, Biology, and Socioeconomic Determinants.
    Siddharth S; Sharma D
    Cancers (Basel); 2018 Dec; 10(12):. PubMed ID: 30558195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of the tumor and obese microenvironment to triple negative breast cancer.
    Kaul K; Misri S; Ramaswamy B; Ganju RK
    Cancer Lett; 2021 Jul; 509():115-120. PubMed ID: 33798632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome disparities in African American women with triple negative breast cancer: a comparison of epidemiological and molecular factors between African American and Caucasian women with triple negative breast cancer.
    Sturtz LA; Melley J; Mamula K; Shriver CD; Ellsworth RE
    BMC Cancer; 2014 Feb; 14():62. PubMed ID: 24495414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IRE1α Disruption in Triple-Negative Breast Cancer Cooperates with Antiangiogenic Therapy by Reversing ER Stress Adaptation and Remodeling the Tumor Microenvironment.
    Harnoss JM; Le Thomas A; Reichelt M; Guttman O; Wu TD; Marsters SA; Shemorry A; Lawrence DA; Kan D; Segal E; Merchant M; Totpal K; Crocker LM; Mesh K; Dohse M; Solon M; Modrusan Z; Rudolph J; Koeppen H; Walter P; Ashkenazi A
    Cancer Res; 2020 Jun; 80(11):2368-2379. PubMed ID: 32265225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting molecular cross-talk between tumor cells and tumor associated macrophage as therapeutic strategy in triple negative breast cancer.
    Shettigar A; Salunke R; Modi D; Mukherjee N
    Int Immunopharmacol; 2023 Jun; 119():110250. PubMed ID: 37163922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor microenvironment: Challenges and opportunities in targeting metastasis of triple negative breast cancer.
    Deepak KGK; Vempati R; Nagaraju GP; Dasari VR; S N; Rao DN; Malla RR
    Pharmacol Res; 2020 Mar; 153():104683. PubMed ID: 32050092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CXCL14 Attenuates Triple-Negative Breast Cancer Progression by Regulating Immune Profiles of the Tumor Microenvironment in a T Cell-Dependent Manner.
    Gibbs C; So JY; Ahad A; Michalowski AM; Son DS; Li Y
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current Advancements of Plant-Derived Agents for Triple-Negative Breast Cancer Therapy through Deregulating Cancer Cell Functions and Reprogramming Tumor Microenvironment.
    Wu TN; Chen HM; Shyur LF
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MCT-1/miR-34a/IL-6/IL-6R signaling axis promotes EMT progression, cancer stemness and M2 macrophage polarization in triple-negative breast cancer.
    Weng YS; Tseng HY; Chen YA; Shen PC; Al Haq AT; Chen LM; Tung YC; Hsu HL
    Mol Cancer; 2019 Mar; 18(1):42. PubMed ID: 30885232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.